Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
If you do not have it, none of what follows can be applied with any precision
Protocol 2: Intermediate approach (experienced researchers) Goal: Multi-target immune modulation with anti-inflammatory support Components: Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly KPV: 200-500 mcg subcutaneously, once daily BPC-157: 250 mcg subcutaneously, twice daily Selank: 250-500 mcg intranasally, once daily Schedule: Monday, Wednesday, Friday: Thymosin alpha-1 Daily AM: KPV + BPC-157 Daily PM: BPC-157 Daily: Selank nasal spray (morning or midday) Duration: 12 weeks on, 4 weeks off Monitoring: Baseline labs, repeat every 4 weeks
Some people are comfortable with that tradeoff
10.1007/978-1-4614-1025-6 28 HeP.ZhangX.WuW.LiuG.LiuS.WangC.et al (2022)
Outside the Bridge, coverage may also apply when these medications are prescribed for specific FDA-approved indications such as type 2 diabetes (Ozempic, Mounjaro) or, for Wegovy, established cardiovascular disease with overweight or obesity
US$ 28.20
US$ 21.01
US$ 22.84
US$ 25.60
US$ 21.30
